Table A.
Writing Group Author Disclosure Table
| Writing Group | Employment | Consultant/Advisory Board/Honoraria |
Speakers’ Bureau | Research Grant | Fellowship Support | Equity Interests/ Stock Options |
Others |
|---|---|---|---|---|---|---|---|
| Robert S. Sheldon, MD, PhD, FHRS |
Libin Cardiovascular Institute of Alberta, Alberta, Canada |
None | None | None | None | None | None |
| Blair P. Grubb II, MD | University of Toledo, Toledo, Ohio |
1; Biotronik; Medtronic, Inc. |
None | 1; Medtronic, Inc. | None | None | None |
| Richard Sutton, DSc, FHRS |
National Heart and Lung Institute, Imperial College, London, United Kingdom |
3; Medtronic, Inc. | 1; St. Jude Medical | 3; Medtronic | None | 3; Boston Scientific Corp. 5; Advanced Circulatory Systems, Inc. |
None |
| Julian M. Stewart, MD, PhD |
New York Medical College, Valhalla, New York |
None | None | 5; National Institutes of Health |
None | None | None |
| Satish R. Raj, MD, MS, MSCI, FHRS |
Libin Cardiovascular Institute of Alberta, Alberta, Canada Vanderbilt University School of Medicine, Nashville, Tennessee |
1; Medtronic, Inc.; GE Healthcare; Lundberk |
None | 1; Dysautonomia International 5; National Institutes of Health |
None | None | Officers/Trustees: 0; Association of Clinical and Translational Sciences; American Autonomic Society; Dysautonomia International Medical Advisory Board; Dysautonomia Information Network; Red Lily Foundation; POTS |
| Hugh Calkins, MD, FHRS, CCDS |
Johns Hopkins University, Baltimore, Maryland |
None | None | 3; Medtronic, Inc.; St. Jude Medical |
None | None | UK None |
| Carlos A. Morillo, MD, FHRS |
McMaster University Population Health Research Institute, Hamilton, Canada |
1; Sanofi Aventis; Biotronik 2; Boehringer Ingelheim; Merck Pharmaceuticals |
1; Boehringer Ingelheim; Sanofi Aventis 2; Merck Pharmaceuticals |
3; St. Jude Medical 4; Medtronic, Inc.; Boston Scientific Corp. |
None | None | None |
| Brian Olshansky, MD, FHRS, CCDS |
The University of Iowa Hospitals, Iowa City, Iowa |
1; Boston Scientific Corp; Boehringer Ingelheim; Medtronic, Inc.; BioControl Medical Ltd; Sanofi Aventis; Amarin; Daiichi Sankyo; Biotronik; On-X; Lundbeck |
None | None | None | None | None |
| Mitchell I. Cohen, MD, FHRS, CCDS |
Phoenix Children’s Hospital, University of Arizona School of Medicine– Phoenix, Arizona Pediatric Cardiology Consultants/ Mednax, Phoenix, Arizona |
None | None | None | None | None | None |
| Win-Kuang Shen, MD, FHRS |
Mayo Clinic, Phoenix, Arizona |
None | None | None | None | None | None |
| Andrew D. Krahn, MD, FHRS |
University of British Columbia, Vancouver, Canada |
1; Medtronic, Inc.; Bayer Healthcare, LLC; Boehringer Ingelheim |
None | 1; Boston Scientific Corp. 2; St. Jude Medical |
None | None | None |
| Roopinder K. Sandhu, MD, FHRS |
University of Alberta, Alberta, Canada |
None | None | None | None | None | None |
| Kenneth A. Mayuga, MD |
Cleveland Clinic Foundation, Cleveland, Ohio |
None | None | None | None | None | None |
| M. Khalil Kanjwal, MD |
John Hopkins University, Baltimore, Maryland |
None | None | None | None | None | None |
| Karen J. Friday, MD | Stanford University School of Medicine, Stanford, California |
None | None | None | None | None | Arbor Pharmaceuticals (Stepson) |
| Denise Tessariol Hachul, MD, PhD |
Heart Institute– University of Sao Paulo Medical School, Sao Paulo, Brazil |
None | None | None | None | None | None |
| Paola Sandroni, MD, PhD |
Mayo Clinic, Rochester, Minnesota |
1; Lundbeck | None | None | None | None | None |
| Michele Brignole, MD |
Ospedali del Tigullio, Lavagna, Italy |
None | None | None | None | None | None |
| Jeffrey P. Moak, MD | Children’s National Medical Center, Washington, District of Columbia |
None | None | None | None | None | None |
| Dennis H. Lau, MBBS, PhD |
Centre for Heart Rhythm Disorders, University of Adelaide; Department of Cardiology, Royal Adelaide Hospital; and South Australian Health and Medical Research Institute, Adelaide, Australia |
None | None | None | 4; National Health and Medical Research Council of Australia |
None | None |
Number Value: 0 = $0; 1 = <$10,000; 2 = >$10,000 to <$25,000; 3 = >$25,000 to <$50,000; 4 = >$50,000 to <$100,000; 5 = >$100,000